Mark Hamner to Antipsychotic Agents
This is a "connection" page, showing publications Mark Hamner has written about Antipsychotic Agents.
Connection Strength
1.621
-
Ziprasidone Augmentation of SSRI Antidepressants in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Pilot Study of Augmentation Therapy. J Clin Psychopharmacol. 2019 Mar/Apr; 39(2):153-157.
Score: 0.530
-
Emerging roles for atypical antipsychotics in chronic post-traumatic stress disorder. Expert Rev Neurother. 2005 Mar; 5(2):267-75.
Score: 0.201
-
Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy. J Clin Psychopharmacol. 2003 Feb; 23(1):15-20.
Score: 0.174
-
Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms. Int Clin Psychopharmacol. 2003 Jan; 18(1):1-8.
Score: 0.173
-
The effects of atypical antipsychotics on serum prolactin levels. Ann Clin Psychiatry. 2002 Sep; 14(3):163-73.
Score: 0.169
-
Characterizing the Effects of Quetiapine in Military Post-Traumatic Stress Disorder. Psychopharmacol Bull. 2018 02 05; 48(2):8-17.
Score: 0.123
-
Plasma prolactin in schizophrenia subjects treated with Seroquel (ICI 204,636). Psychopharmacol Bull. 1996; 32(1):107-10.
Score: 0.106
-
An open-label assessment of aripiprazole in the treatment of PTSD. Psychopharmacol Bull. 2009; 42(1):69-80.
Score: 0.066
-
Quetiapine improves sleep disturbances in combat veterans with PTSD: sleep data from a prospective, open-label study. J Clin Psychopharmacol. 2005 Aug; 25(4):387-8.
Score: 0.052
-
Efficacy of Quetiapine Monotherapy in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Trial. Am J Psychiatry. 2016 Dec 01; 173(12):1205-1212.
Score: 0.028